SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Rozek Alexander Buffett (Last) (First) (Middle) 1601 DODGE STREET SUITE 3300 (Street) OMAHA NE 68102 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol BOSTON OMAHA Corp [ BOC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner X Officer (give title below) Other (specify below) Co-CEO, Co-President
	3. Date of Earliest Transaction (Month/Day/Year) 12/22/2022
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, par value $0.001 per share	12/22/2022		J(1)		20,000	D	(1)	1,056,203	D(2)(3)(4)
Class A common stock, par value $0.001 per share	06/02/2023		J(5)		128,550	D	(5)	939,253	D(2)(3)(4)
Class A common stock, par value $0.001 per share	06/05/2023		S		11,600(6)	D	$19.7449(7)	927,653	D(2)(3)(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Rozek Alexander Buffett (Last) (First) (Middle) 1601 DODGE STREET SUITE 3300 (Street) OMAHA NE 68102 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director X 10% Owner X Officer (give title below) Other (specify below) Co-CEO, Co-President

1. Name and Address of Reporting Person* Boulderado Group, LLC (Last) (First) (Middle) 292 NEWBURY ST., SUITE 333 (Street) BOSTON MA 02115 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Boulderado Partners, LLC (Last) (First) (Middle) 292 NEWBURY ST., SUITE 333 (Street) BOSTON MA 02115 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Boulderado Capital, LLC (Last) (First) (Middle) 292 NEWBURY ST., SUITE 333 (Street) BOSTON MA 02115 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. On December 22, 2022, Boulderado Partners, LLC ("BP") redeemed interests of BP held by two foundations that are limited partners of BP in a specific A-3 zero fee series (collectively, the "Foundations"), in consideration for the distribution to each such Foundation of 10,000 shares of Class A common stock of the Issuer. Mr. Rozek is the President of each of the Foundations and may exercise voting and dispositive power over the Class A common stock held by the Foundations, but Mr. Rozek disclaims beneficial ownership over such shares and this report shall not be deemed an admission of beneficial ownership of these securities for Section 16 or for any other purposes.

2. Boulderado Capital, LLC ("BC"), Boulderado Group, LLC ("BG") and Mr. Rozek disclaim beneficial ownership except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission of beneficial ownership of these securities for Section 16 or for any other purposes.

3. Mr. Rozek serves as a director of the Issuer and is the Co-Chief Executive Officer and Co-President of the Issuer.

4. The reported shares are directly owned by BP, other than the shares distributed to the Foundations as described in footnote (1), to the Foundation and the Trusts as described in footnote (5) and as sold by the Medical Trust as described in footnote (6). BC is the managing member of BP. BG is the investment manager of BP. Mr. Rozek is the managing member of BP, BC and BG. BP, BC, BG and Mr. Rozek disclaim beneficial ownership except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission of beneficial ownership of these securities for Section 16 or for any other purposes.

5. On June 2, 2023, BP redeemed interests of BP held by one of the Foundations and three trusts that were limited partners of BP (collectively, the "Trusts"), including the Doris Buffett Medical Support Trust (the "Medical Trust"), in consideration of the distribution to one of the Foundations of 43,000 shares, and to the Trusts of 11,600 shares, 11,800 shares and 62,150 shares, respectively, of Class A common stock of the Issuer. Mr. Rozek is the President of each of the Foundations and is a trustee of each of the Trusts, and may exercise voting and dispositive power over the Class A common stock held by the Foundations and the Trusts. BP, BC, BG and Mr. Rozek disclaim beneficial ownership over such shares held by the Foundations and each of the Trusts, except that with regard to the Medical Trust, Mr. Rozek disclaims beneficial ownership except to the extent of his pecuniary interest therein.

6. The shares reported in Column 4 were sold by the Medical Trust.

7. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.70 to $19.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4.

	/s/ Alexander B. Rozek	06/06/2023
	/s/ Alexander B. Rozek on behalf of Boulderado Group, LLC, as its managing member	06/06/2023
	/s/ Alexander B. Rozek on behalf of Boulderado Partners, LLC, as Managing Member of Boulderado Capital, LLC, its managing member	06/06/2023
	/s/ Alexander B. Rozek on behalf of Boulderado Capital, LLC, as its managing member	06/06/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.